» Authors » Anthony J Slavin

Anthony J Slavin

Explore the profile of Anthony J Slavin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 721
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zamvil S, Slavin A
Neurol Neuroimmunol Neuroinflamm . 2015 Jan; 2(1):e62. PMID: 25635259
While neuromyelitis optica (NMO) immunoglobulin (Ig) G is considered the hallmark serologic marker of NMO, its association is not absolute, as NMO IgG is not detected in approximately one-fourth of...
2.
Shetty A, Gupta S, Varrin-Doyer M, Weber M, Prodhomme T, Molnarfi N, et al.
Neurol Neuroimmunol Neuroinflamm . 2014 Oct; 1(2):e22. PMID: 25340074
Objective: Studies evaluating T-cell recognition of myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis (MS) and its model, experimental autoimmune encephalomyelitis (EAE), have focused mostly on its 117 amino acid (aa)...
3.
Varrin-Doyer M, Shetty A, Spencer C, Schulze-Topphoff U, Weber M, Bernard C, et al.
Neurol Neuroimmunol Neuroinflamm . 2014 Oct; 1(2):e20. PMID: 25340072
Objective: Recently, we reported that the 218 amino acid murine full-length myelin oligodendrocyte glycoprotein (MOG) contains novel T-cell epitopes p119-132, p181-195, and p186-200, located within its transmembrane and cytoplasmic domains,...
4.
Molnarfi N, Schulze-Topphoff U, Weber M, Patarroyo J, Prodhomme T, Varrin-Doyer M, et al.
J Exp Med . 2013 Dec; 210(13):2921-37. PMID: 24323356
Whether B cells serve as antigen-presenting cells (APCs) for activation of pathogenic T cells in the multiple sclerosis model experimental autoimmune encephalomyelitis (EAE) is unclear. To evaluate their role as...
5.
Lewis N, Haxhinasto S, Anderson S, Stefanopoulos D, Fogal S, Adusumalli P, et al.
J Immunol . 2013 Feb; 190(7):3533-40. PMID: 23436932
Sphingosine-1-phosphate (S1P) receptors are critical for lymphocyte egress from secondary lymphoid organs, and S1P receptor modulators suppress lymphocyte circulation. However, the role of S1P receptors on monocytes is less clear....
6.
Weber M, Prodhomme T, Patarroyo J, Molnarfi N, Karnezis T, Lehmann-Horn K, et al.
Ann Neurol . 2010 Jul; 68(3):369-83. PMID: 20641064
Objective: Clinical studies indicate that anti-CD20 B-cell depletion may be an effective multiple sclerosis (MS) therapy. We investigated mechanisms of anti-CD20-mediated immune modulation using 2 paradigms of experimental autoimmune encephalomyelitis...
7.
Slavin A, Zamvil S
Neurology . 2010 Jul; 75(5):388-9. PMID: 20610831
No abstract available.
8.
Stremmel C, Siebenhaar R, Croner R, Reingruber B, Slavin A, Hohenberger W
Int J Colorectal Dis . 2005 Apr; 20(6):485-93. PMID: 15812645
Background And Aims: T cells of tumor-bearing mice or cancer patients exhibit an immune dysfunction, enabling the tumor to escape immune surveillance. Methods: The experiments are based on EL4 thymoma...
9.
Tarner I, Slavin A, McBride J, Levicnik A, Smith R, Nolan G, et al.
Ann N Y Acad Sci . 2003 Nov; 998:512-9. PMID: 14592922
Autoimmune disorders represent inappropriate immune responses directed at self-tissue. Antigen-specific CD4+ T cells and antigen-presenting dendritic cells (DCs) are important mediators in the pathogenesis of auto-immune disease and thus are...
10.
Slavin A, Tarner I, Nakajima A, Urbanek-Ruiz I, McBride J, Contag C, et al.
Autoimmun Rev . 2003 Jul; 1(4):213-9. PMID: 12848998
Autoimmune disorders represent inappropriate immune responses directed at self-tissue. Because CD4+ T cells are important mediators in the pathogenesis of autoimmune disease, they are ideal candidates for cell-based gene therapy....